Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/06/2005US20050223418 Porcine CMP-N-Acetylneuraminic acid hydroxylase gene
10/06/2005US20050223417 Germ line and somatic cells comprising a mutant p27kip1 protein lacking a Cdk2 phosphorylation site; side effect reduction
10/06/2005US20050223416 C1 inhibitor produced in the milk of transgenic mammals
10/06/2005US20050222404 Isolation of nucleic acids using a polycationic polymer as precipitation agent
10/06/2005US20050222402 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/06/2005US20050222401 Noved human proteases and polynucleotides encoding the same
10/06/2005US20050222400 Aptamer constructs
10/06/2005US20050222393 Chemokine receptor obtained from a cdna library of fetal liver-spleen
10/06/2005US20050222392 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/06/2005US20050222391 Method of constructing antibody
10/06/2005US20050222390 The peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases
10/06/2005US20050222389 Method for preparing modified polypeptides
10/06/2005US20050222388 Fusion protein of hiv regulatory/accessory proteins
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222386 Biomolecule transduction motif sim-2-btm and the use thereof
10/06/2005US20050222385 Hybrid and tandem expression of neisserial proteins
10/06/2005US20050222073 Antisense modulation of thyroid hormone receptor interactor 6 expression
10/06/2005US20050222072 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
10/06/2005US20050222069 Optimization of immunomodulatory properties of genetic vaccines
10/06/2005US20050222068 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
10/06/2005US20050222067 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell
10/06/2005US20050222066 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
10/06/2005US20050222065 Vascular therapeutics
10/06/2005US20050222063 Methylenetetrahydrofolate reductase inhibitors and use thereof
10/06/2005US20050222062 Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
10/06/2005US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/06/2005US20050222058 Antisense modulation of mucin 1, transmembrane expression
10/06/2005US20050222057 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
10/06/2005US20050222056 Heterocyclic compounds and their use in the detection of nucleic acids
10/06/2005US20050222033 Receptor based antagonists and methods of making and using
10/06/2005US20050222028 BMP-9 compositions and methods for inducing differentiation of cholinergic neurons
10/06/2005US20050222023 Albumin-fused kunitz domain peptides
10/06/2005US20050222011 Selectin ligands
10/06/2005US20050222009 Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier
10/06/2005US20050221493 Recombinant virus production for the manufacturing of vaccines
10/06/2005US20050221492 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
10/06/2005US20050221491 In vivo selection method for determining inhibitory RNA molecules
10/06/2005US20050221490 DNA virus microRNA and methods for inhibiting same
10/06/2005US20050221489 Recombinant negative strand virus rna expression systems and vaccines
10/06/2005US20050221488 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods
10/06/2005US20050221478 Control of es cell self renewal and lineage specification, and medium therefor
10/06/2005US20050221474 Gene promoters
10/06/2005US20050221467 Polypeptides which codes mutant phytoene desaturase gene; genetic engineered cells
10/06/2005US20050221466 Alanine 2,3,aminomutase
10/06/2005US20050221463 Novel human thymosin protein and polynucleotides encoding the same
10/06/2005US20050221461 Genetic engineered Dna; textile cleaning compounds
10/06/2005US20050221460 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
10/06/2005US20050221458 proteins having oxidase or oxidoreductase activity, used to control growth of insects, enabling finer silk thread production; gene expression inhibition; genetic engineering
10/06/2005US20050221453 L-cysteine producing microorganism and method for producing L-cysteine
10/06/2005US20050221451 Fermentation process for the preparation of L-amino acids using strains of the family enterobacteriaceae
10/06/2005US20050221449 Of E. coli with a deletion of 39 bp (-56 to -18) of an attenuator; culturing a host cell transformed with a recombinant vector containing the sequence and recovering L-threonine
10/06/2005US20050221447 Mannosyl transfer with regeneration of GDP-mannose
10/06/2005US20050221446 Methods for producing hyaluronic acid in a Bacillus cell
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221444 Expression cassette comprising a polypeptide with a promoter sequence, a translation initiation sequence, a first inclusion body fusion partner, suppressable stop codon,cleavable peptide linkers, a fusion tag, and a transcription terminator sequence; antidiabetic agents; viral infections
10/06/2005US20050221443 Tumor necrosis factor super family agonists
10/06/2005US20050221442 Bacterial host cell for the direct expression of peptides
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221439 Genes of an otitis media isolate of haemophilus influenzae
10/06/2005US20050221438 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for grafting enhancement, graft versus host (GvH) inhibition, graft versus tumor (GvT) stimulation, for the prevention or therapy of tumors and/or of microorganism infections
10/06/2005US20050221437 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/06/2005US20050221436 Human neuropeptide Y-like G protein-coupled receptor
10/06/2005US20050221435 Biological material for preparing pharmaceutical compositions intended for treating mammals
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221432 Altering the cellular secretion rate of a protein comprising the steps of modulating the activity of at least one UPR pathway component in a cell and culturing the cell; useful for producing high levels of proteins for therapeutic, diagnostic or research purposes
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
10/06/2005US20050221430 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
10/06/2005US20050221429 Host cells containing multiple integrating vectors comprising an amplifiable marker
10/06/2005US20050221428 Chimeric neuropeptide Y receptors
10/06/2005US20050221427 Method for screening restriction endonucleases
10/06/2005US20050221426 Polynucleotide having a sequence encoding a mutant cyclic nucleotide-gated channel with at least one mutation that decreases divalent cation-mediated blockage of cation flux; and at least one mutation that makes the channel more sensitive to cAMP than a channel that does not have the mutation
10/06/2005US20050221425 promoter is induced by a reduction in temperature; can be used for regulated expression of proteins, both homologous and heterologous, very efficiently and economically
10/06/2005US20050221423 Bacillus host cell
10/06/2005US20050221422 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221394 Ion channel
10/06/2005US20050221384 Combinatorial libraries of monomer domains
10/06/2005US20050221383 Osteoarthritis biomarkers and uses thereof
10/06/2005US20050221380 Method for determination of the responsiveness of an individual to mistletoe lectin
10/06/2005US20050221378 Polynucleotides formed by hybridization of oligonucleotides, then ligation with synthetases and denaturing to form complementary DNA; genetic engineering
10/06/2005US20050221376 Metalloproteinase ADAM 22
10/06/2005US20050221372 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
10/06/2005US20050221371 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/06/2005US20050221370 Systems and methods for ordering, performing, and reporting genetic screening
10/06/2005US20050221369 BGL3 beta-glucosidase and nucleic acids encoding the same
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221359 Cospeptin, cosmedin and their uses
10/06/2005US20050221356 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof
10/06/2005US20050221355 cDNA for human methylenetetrahydrofolate reductase and uses thereof
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221345 Thioredoxin h homologs
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221343 Self-assembling split-fluorescent protein systems
10/06/2005US20050221342 Nucleic acids and polypeptides
10/06/2005US20050221340 Computer-directed assembly of a polynucleotide encoding a target polypetide
10/06/2005US20050221338 Novel fluorescent protein and gene encoding the same
10/06/2005US20050221335 Reporter gene
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221329 Use of fluorescent molecular beacons in the detection of methylated nucleic acid
10/06/2005US20050221328 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
1 ... 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 ... 4023